Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Point-of-Care Infectious Disease Diagnostics & Testing market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Point-of-Care Infectious Disease Diagnostics & Testing market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027. Segmented by Category HIV POC Clostridium difficile POC HBV POC Pneumonia or Streptococcus associated infections Respiratory syncytial virus (RSV) POC HPV POC Influenza/Flu POC Other Infectious Disease POC Segmented by End User/Segment Hospitals Clinics Home Assisted Living Healthcare Facilities Laboratories Others Segmented by Country North America United States Canada Mexico Europe Germany France UK Italy Russia Spain Asia Pacific China Japan Korea Southeast Asia India Australasia Central & South America Brazil Argentina Colombia Middle East & Africa Iran Israel Turkey South Africa Saudi Arabia Key manufacturers included in this survey Trivitron Healthcare Trinity Biotech Thermo Fisher Scientific Inc Sight Diagnostics Ltd. Siemens Healthineers Roche Quest Diagnostics Inc. Ortho-Clinical Diagnostics OJ-Bio Ltd. Gene POC Chembio Diagnostics Inc. Cardinal Health Bio-Rad Labs Inc. bioMérieux SA BD & Company Abbott

List of Figures

Figure Point-of-Care Infectious Disease Diagnostics & Testing Picture
Figure Global Point-of-Care Infectious Disease Diagnostics & Testing Sales Value (Million USD) and Growth Rate (2016-2027)
Figure Global Point-of-Care Infectious Disease Diagnostics & Testing Sales Value CAGR (2020-2027) by Region
Figure Global Point-of-Care Infectious Disease Diagnostics & Testing Sales Value Market Share by Company, 2020
Figure Product Picture of HIV POC
Figure Product Picture of Clostridium difficile POC
Figure Product Picture of HBV POC
Figure Product Picture of Pneumonia or Streptococcus associated infections
Figure Product Picture of Respiratory syncytial virus (RSV) POC
Figure Product Picture of HPV POC
Figure Product Picture of Influenza/Flu POC
Figure Product Picture of Other Infectious Disease POC
Figure Global Point-of-Care Infectious Disease Diagnostics & Testing Sales Value Market Share by Category, 2020
Figure North America Point-of-Care Infectious Disease Diagnostics & Testing Sales Value Market Share by Category, 2020
Figure Europe Point-of-Care Infectious Disease Diagnostics & Testing Sales Value Market Share by Category, 2020
Figure Asia Pacific Point-of-Care Infectious Disease Diagnostics & Testing Sales Value Market Share by Category, 2020
Figure Central & South America Point-of-Care Infectious Disease Diagnostics & Testing Sales Value Market Share by Category, 2020
Figure Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Sales Value Market Share by Category, 2020
Figure Point-of-Care Infectious Disease Diagnostics & Testing in Hospitals
Figure Global Point-of-Care Infectious Disease Diagnostics & Testing Market: Hospitals (2016-2021)
Figure Point-of-Care Infectious Disease Diagnostics & Testing in Clinics
Figure Global Point-of-Care Infectious Disease Diagnostics & Testing Market: Clinics (2016-2021)
Figure Point-of-Care Infectious Disease Diagnostics & Testing in Home
Figure Global Point-of-Care Infectious Disease Diagnostics & Testing Market: Home (2016-2021)
Figure Point-of-Care Infectious Disease Diagnostics & Testing in Assisted Living Healthcare Facilities
Figure Global Point-of-Care Infectious Disease Diagnostics & Testing Market: Assisted Living Healthcare Facilities (2016-2021)
Figure Point-of-Care Infectious Disease Diagnostics & Testing in Laboratories
Figure Global Point-of-Care Infectious Disease Diagnostics & Testing Market: Laboratories (2016-2021)
Figure Point-of-Care Infectious Disease Diagnostics & Testing in Others
Figure Global Point-of-Care Infectious Disease Diagnostics & Testing Sales Value Market Share by End User/Segment, 2020
Figure North America Point-of-Care Infectious Disease Diagnostics & Testing Sales Value Market Share by End User/Segment, 2020
Figure Europe Point-of-Care Infectious Disease Diagnostics & Testing Sales Value Market Share by End User/Segment, 2020
Figure Asia Pacific Point-of-Care Infectious Disease Diagnostics & Testing Sales Value Market Share by End User/Segment, 2020
Figure Central & South America Point-of-Care Infectious Disease Diagnostics & Testing Sales Value Market Share by End User/Segment, 2020
Figure Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Sales Value Market Share by End User/Segment, 2020
Figure Global Point-of-Care Infectious Disease Diagnostics & Testing Sales Value Market Share by Region (2016-2021)
Figure North America Point-of-Care Infectious Disease Diagnostics & Testing Sales Value (Million USD) Status (2016-2021)
Figure Europe Point-of-Care Infectious Disease Diagnostics & Testing Sales Value (Million USD) Status (2016-2021)
Figure Asia Pacific Point-of-Care Infectious Disease Diagnostics & Testing Sales Value (Million USD) Status (2016-2021)
Figure Central & South America Point-of-Care Infectious Disease Diagnostics & Testing Sales Value (Million USD) Status (2016-2021)
Figure Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Sales Value (Million USD) Status (2016-2021)
Figure North America Point-of-Care Infectious Disease Diagnostics & Testing Sales Value Market Share by Country, 2020
Figure United States Point-of-Care Infectious Disease Diagnostics & Testing Sales Value (Million USD) Status (2016-2021)
Figure Canada Point-of-Care Infectious Disease Diagnostics & Testing Sales Value (Million USD) Status (2016-2021)
Figure Mexico Point-of-Care Infectious Disease Diagnostics & Testing Sales Value (Million USD) Status (2016-2021)

Table of Contents1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Status and Forecast (2016-2027) 1.3.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis2 Global Point-of-Care Infectious Disease Diagnostics & Testing Supply by Company 2.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Sales Value by Company 2.2 Point-of-Care Infectious Disease Diagnostics & Testing Sales Area of Main Manufacturers 2.3 Trend of Concentration Rate3 Global and Regional Point-of-Care Infectious Disease Diagnostics & Testing Market Status by Category 3.1 Point-of-Care Infectious Disease Diagnostics & Testing Category Introduction 3.1.1 HIV POC 3.1.2 Clostridium difficile POC 3.1.3 HBV POC 3.1.4 Pneumonia or Streptococcus associated infections 3.1.5 Respiratory syncytial virus (RSV) POC 3.1.6 HPV POC 3.1.7 Influenza/Flu POC 3.1.8 Other Infectious Disease POC 3.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Market by Category 3.3 North America: by Category 3.4 Europe: by Category 3.5 Asia Pacific: by Category 3.6 Central & South America: by Category 3.7 Middle East & Africa: by Category4 Global and Regional Point-of-Care Infectious Disease Diagnostics & Testing Market Status by End User/Segment 4.1 Point-of-Care Infectious Disease Diagnostics & Testing Segment by End User/Segment 4.1.1 Hospitals 4.1.2 Clinics 4.1.3 Home 4.1.4 Assisted Living Healthcare Facilities 4.1.5 Laboratories 4.1.6 Others 4.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Market by End User/Segment 4.3 North America: by End User/Segment 4.4 Europe: by End User/Segment 4.5 Asia Pacific: by End User/Segment 4.6 Central & South America: by End User/Segment 4.7 Middle East & Africa: by End User/Segment5 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Status by Region 5.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Market by Region 5.2 North America Point-of-Care Infectious Disease Diagnostics & Testing Market Status 5.3 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Status 5.4 Asia Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Status 5.5 Central & South America Point-of-Care Infectious Disease Diagnostics & Testing Market Status 5.6 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Status6 North America Point-of-Care Infectious Disease Diagnostics & Testing Market Status 6.1 North America Point-of-Care Infectious Disease Diagnostics & Testing Market by Country 6.2 United States 6.3 Canada 6.4 Mexico7 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Status 7.1 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market by Country 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain8 Asia Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Status 8.1 Asia Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market by Country 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia9 Central & South America Point-of-Care Infectious Disease Diagnostics & Testing Market Status 9.1 Central & South America Point-of-Care Infectious Disease Diagnostics & Testing Market by Country 9.2 Brazil 9.3 Argentina 9.4 Colombia10 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Status 10.1 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market by Country 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia11 Major Downstream Customers Analysis 11.1 Customer One Analysis 11.2 Customer Two Analysis 11.3 Customer Three Analysis 11.4 Customer Four Analysis12 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast by Category and by End User/Segment 12.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Sales Value Forecast (2022-2027) 12.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Forecast by Category 12.3 Global Point-of-Care Infectious Disease Diagnostics & Testing Forecast by End User/Segment13 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast by Region/Country 13.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast14 Key Participants Company Information 14.1 Trivitron Healthcare 14.1.1 Company Information 14.1.2 Point-of-Care Infectious Disease Diagnostics & Testing Product Introduction 14.1.3 Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics & Testing Sales Value, Gross Margin and Global Share (2019-2021) 14.1.4 SWOT Analysis 14.2 Trinity Biotech 14.2.1 Company Information 14.2.2 Point-of-Care Infectious Disease Diagnostics & Testing Product Introduction 14.2.3 Trinity Biotech Point-of-Care Infectious Disease Diagnostics & Testing Sales Value, Gross Margin and Global Share (2019-2021) 14.2.4 SWOT Analysis 14.3 Thermo Fisher Scientific Inc 14.3.1 Company Information 14.3.2 Point-of-Care Infectious Disease Diagnostics & Testing Product Introduction 14.3.3 Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics & Testing Sales Value, Gross Margin and Global Share (2019-2021) 14.3.4 SWOT Analysis 14.4 Sight Diagnostics Ltd. 14.4.1 Company Information 14.4.2 Point-of-Care Infectious Disease Diagnostics & Testing Product Introduction 14.4.3 Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Sales Value, Gross Margin and Global Share (2019-2021) 14.4.4 SWOT Analysis 14.5 Siemens Healthineers 14.5.1 Company Information 14.5.2 Point-of-Care Infectious Disease Diagnostics & Testing Product Introduction 14.5.3 Siemens Healthineers Point-of-Care Infectious Disease Diagnostics & Testing Sales Value, Gross Margin and Global Share (2019-2021) 14.5.4 SWOT Analysis 14.6 Roche 14.6.1 Company Information 14.6.2 Point-of-Care Infectious Disease Diagnostics & Testing Product Introduction 14.6.3 Roche Point-of-Care Infectious Disease Diagnostics & Testing Sales Value, Gross Margin and Global Share (2019-2021) 14.6.4 SWOT Analysis 14.7 Quest Diagnostics Inc. 14.7.1 Company Information 14.7.2 Point-of-Care Infectious Disease Diagnostics & Testing Product Introduction 14.7.3 Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Sales Value, Gross Margin and Global Share (2019-2021) 14.7.4 SWOT Analysis 14.8 Ortho-Clinical Diagnostics 14.8.1 Company Information 14.8.2 Point-of-Care Infectious Disease Diagnostics & Testing Product Introduction 14.8.3 Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics & Testing Sales Value, Gross Margin and Global Share (2019-2021) 14.8.4 SWOT Analysis 14.9 OJ-Bio Ltd. 14.9.1 Company Information 14.9.2 Point-of-Care Infectious Disease Diagnostics & Testing Product Introduction 14.9.3 OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Sales Value, Gross Margin and Global Share (2019-2021) 14.9.4 SWOT Analysis 14.10 Gene POC 14.10.1 Company Information 14.10.2 Point-of-Care Infectious Disease Diagnostics & Testing Product Introduction 14.10.3 Gene POC Point-of-Care Infectious Disease Diagnostics & Testing Sales Value, Gross Margin and Global Share (2019-2021) 14.10.4 SWOT Analysis 14.11 Chembio Diagnostics Inc. 14.12 Cardinal Health 14.13 Bio-Rad Labs Inc. 14.14 bioMérieux SA 14.15 BD & Company 14.16 Abbott15 Conclusion16 Methodology